SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis-Reference-Cited by-同舟云学术

SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis

Published:2018-05-18 Issue:6390 Volume:360 Page:800-805
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Muhar Matthias¹^ORCID,Ebert Anja¹^ORCID,Neumann Tobias¹^ORCID,Umkehrer Christian¹^ORCID,Jude Julian¹^ORCID,Wieshofer Corinna²,Rescheneder Philipp³,Lipp Jesse J.¹,Herzog Veronika A.⁴,Reichholf Brian⁴,Cisneros David A.¹^ORCID,Hoffmann Thomas¹^ORCID,Schlapansky Moritz F.¹^ORCID,Bhat Pooja⁴,von Haeseler Arndt³^ORCID,Köcher Thomas⁵^ORCID,Obenauf Anna C.¹^ORCID,Popow Johannes²,Ameres Stefan L.⁴^ORCID,Zuber Johannes¹⁶^ORCID

Affiliation:

1. Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), 1030 Vienna, Austria.

2. Boehringer Ingelheim–Regional Center Vienna GmbH and Company KG, 1121 Vienna, Austria.

3. Center for Integrative Bioinformatics Vienna, Max F. Perutz Laboratories, University of Vienna and Medical University of Vienna, 1030 Vienna, Austria.

4. Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), VBC, 1030 Vienna, Austria.

5. Vienna Biocenter Core Facilities (VBCF), 1030 Vienna, Austria.

6. Medical University of Vienna, VBC, 1030 Vienna, Austria.

Abstract

Profiling transcription—a SLAM dunk Identification of the direct target genes of transcription factors could shed light on how healthy cells become malignant. Muhar et al. applied a modified version of a transcript-mapping method called SLAM-seq to identify the target genes of two transcriptional regulators of major interest in cancer research (see the Perspective by Sabò and Amati). The MYC oncoprotein selectively activates transcription of just a few genes, primarily those involved in basic cell metabolism. In contrast, BRD4, a bromodomain-containing protein that is being targeted for cancer therapy, activates transcription of many genes. Science , this issue p. 800 ; see also p. 713

Funder

H2020 European Research Council

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference45 articles.

1. Transcriptional Regulation and Its Misregulation in Disease

2. Targeting the cancer epigenome for therapy

3. The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition

4. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

5. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells;Journal of Advanced Research;2024-02

2. An end-to-end workflow to study newly synthesized mRNA following rapid protein depletion inSaccharomyces cerevisiae;2024-01-26

3. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage;Nucleic Acids Research;2024-01-16

4. Transcriptome Dynamics in Mouse Amygdala under Acute and Chronic Stress Revealed by Thio-labeled RNA Sequencing;2024-01-12

5. Cytoplasmic Accumulation of Histones Induced by BET Inhibition Protects Cells from C9orf72 Poly(PR)‐Induced Cell Death;Advanced Biology;2024-01-11